Aurora Cannabis Inc. (TSX:ACB): Quarterly Results Show Surging Revenue Growth With Many Opportunities and Challenges in the Background

Aurora Cannabis Inc. (TSX:ACB)(NYSE:ACB) sees strong sales momentum but mounting losses, as massive opportunities come with challenges.

| More on:

Aurora Cannabis (TSX:ACB)(NYSE:ACB) reported another quarter of surging sales growth, with sequential revenue growth topping 80%, and year-over-year revenue growth coming in at an impressive 363%.

Capturing approximately 20% market share in the consumer market, Aurora is benefitting from its first-mover advantage in many geographies and product segments.

Growing production to meet booming demand

The company sold primarily to its provincial partners and has ramped up production significantly to meet the booming demand.

Production should reach 150,000 kg by the end of the month compared to current production of 120,000 kg. That’s a 25% increase.

Rising costs

There are some challenges that are rearing their heads, and although management is saying that these are temporary, we should monitor the situation.

The cost per gram rose $0.47 from last quarter to $1.92 per gram. This was due to temporary inefficiencies, as production is ramping up, as well as increased labour costs and increased investment costs in preparation of legalization.

Going forward, general and administrative costs should be expected to rise as the company’s expansion and growth continues.

Increasing research and development costs can be expected, as the company continues its scientific research into the medical benefits of cannabis through clinical trials and medical case studies as well as its investment in advocacy and education.

Aurora Cannabis’s focus remains on the medical market, and management is working hard at increasing its credibility as a supplier to the medical industry.

As a reflection of its success, we have seen a 10% increase in its patient base in Canada to nearly 73,000 patients, and the company is directing a significant supply of product to Europe, which is more like a pharmaceutical model.

Pricing pressure?

In terms of pricing pressure, and to those of us who are concerned with the idea that marijuana is a commodity that will be subject to pricing pressure, we can rest assured that this may not materialize so easily.

Because demand is so much greater than supply, Aurora management estimates that it will be at least five years before we would have an oversupply situation. The thing to remember is that while there is no shortage of cannabis, there is a big shortage of legal cannabis that is certified to be distributed.

Final thoughts

In closing, I think that while the business is one that seems destined for greatness, one must remember that there will be speed bumps along the way.

We have to remember that a stock that is factoring in overly bullish expectations is therefore mispriced, at least in the short term, and it will not react well to these inevitable speed bumps.

Once again, for investors who want exposure to the marijuana sector, choose your entry points wisely, take profits, and diversify by holding a basket of marijuana stocks.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Karen Thomas has no position in any of the stocks mentioned.

More on Investing

money goes up and down in balance
Dividend Stocks

Is Fiera Capital Stock a Buy for its 8.6% Dividend Yield?

Down almost 40% from all-time highs, Fiera Capital stock offers you a tasty dividend yield right now. Is the TSX…

Read more »

tsx today
Stock Market

TSX Today: What to Watch for in Stocks on Wednesday, December 11

In addition to the U.S. inflation report, the Bank of Canada’s interest rate decision and press conference will remain on…

Read more »

Blocks conceptualizing Canada's Tax Free Savings Account
Dividend Stocks

How to Use Your TFSA to Double Your TFSA Contribution

If you're looking to double up that TFSA contribution, there is one dividend stock I would certainly look to in…

Read more »

Income and growth financial chart
Investing

A Top-Performing U.S. Stock That Canadian Investors Really Should Own

Amazon (NASDAQ:AMZN) is starting to run faster in the AI race, making it a top U.S. pick for 2025.

Read more »

Person uses a tablet in a blurred warehouse as background
Tech Stocks

2 Canadian AI Stocks Poised for Significant Gains

Here are two top AI stocks long-term investors may want to consider before the end of the year.

Read more »

man touches brain to show a good idea
Investing

3 No Brainer Tech Stocks to Buy With $500 Right Now

Here are three no-brainer tech stocks long-term investors on a limited budget may want to consider right now.

Read more »

woman looks at iPhone
Dividend Stocks

Retirees: Is TELUS Stock a Risky Buy?

TELUS stock has long been a strong dividend provider, but what should investors consider now after recent earnings?

Read more »

Concept of multiple streams of income
Dividend Stocks

Is goeasy Stock Still Worth Buying for Growth Potential?

goeasy offers a powerful combination of growth and dividend-based return potential, but it might be less promising for growth alone.

Read more »